Selected article for: "activity study and log reduction"

Author: Kristjánsson, Jón Magnús; Rolfsson, Óttar
Title: Virucidal activity of a proprietary blend of plant-based oils (Viruxal) against SARS-CoV-2 and influenza viruses – an in vitro study
  • Cord-id: fsmbdz4n
  • Document date: 2021_6_1
  • ID: fsmbdz4n
    Snippet: Background The emergence of a novel coronavirus known as SARS-CoV-2 resulting in a global pandemic COVID-19 has led to a dramatic loss of life worldwide and presented an unprecedented challenge to public health. Viruxal is a medical device in a form of a nasal and oral spay containing a a proprietary blend of plant-based oils which acts against enveloped viruses. The aim of this study was to evaluate the virus deactivation activity of Viruxal against SARS-CoV-2 and Influenza A(H1N1) viruses. Met
    Document: Background The emergence of a novel coronavirus known as SARS-CoV-2 resulting in a global pandemic COVID-19 has led to a dramatic loss of life worldwide and presented an unprecedented challenge to public health. Viruxal is a medical device in a form of a nasal and oral spay containing a a proprietary blend of plant-based oils which acts against enveloped viruses. The aim of this study was to evaluate the virus deactivation activity of Viruxal against SARS-CoV-2 and Influenza A(H1N1) viruses. Methods An assay to detect virucidal activity was performed with four concentrations of Viruxal on two virus suspensions. Assessments were made based on log reduction values measured from the assay. Results Viruxal exhibited virucidal activity by reducing virus titer more than 90% for the enveloped viruses SARS-CoV-2 and influenza A(H1N1) after 30 minutes contact. Conclusions Viruxal was validated for its potential usefulness as a medical device for treatment and prevention of enveloped respiratory viruses.

    Search related documents:
    Co phrase search for related documents
    • action mode and long chain: 1
    • active ingredient and log reduction: 1, 2, 3
    • active ingredient and log reduction value: 1, 2
    • active ingredient and lrv log reduction value: 1
    • acute lung damage and long chain: 1
    • acute pneumonia and additional protection: 1